nodes	percent_of_prediction	percent_of_DWPC	metapath
Methacholine—Seasonal allergy—Metformin—polycystic ovary syndrome	0.162	0.29	CcSEcCtD
Methacholine—Rhinitis seasonal—Metformin—polycystic ovary syndrome	0.156	0.279	CcSEcCtD
Methacholine—Respiratory distress—Metformin—polycystic ovary syndrome	0.0536	0.0957	CcSEcCtD
Methacholine—Chest discomfort—Metformin—polycystic ovary syndrome	0.0385	0.0687	CcSEcCtD
Methacholine—Lightheadedness—Metformin—polycystic ovary syndrome	0.0305	0.0544	CcSEcCtD
Methacholine—Bradycardia—Metformin—polycystic ovary syndrome	0.0174	0.0311	CcSEcCtD
Methacholine—Syncope—Metformin—polycystic ovary syndrome	0.0133	0.0238	CcSEcCtD
Methacholine—Loss of consciousness—Metformin—polycystic ovary syndrome	0.0131	0.0234	CcSEcCtD
Methacholine—Chest pain—Metformin—polycystic ovary syndrome	0.0127	0.0226	CcSEcCtD
Methacholine—Shock—Metformin—polycystic ovary syndrome	0.012	0.0213	CcSEcCtD
Methacholine—Hypotension—Metformin—polycystic ovary syndrome	0.0114	0.0203	CcSEcCtD
Methacholine—Pruritus—Metformin—polycystic ovary syndrome	0.00859	0.0153	CcSEcCtD
Methacholine—Dizziness—Metformin—polycystic ovary syndrome	0.00803	0.0143	CcSEcCtD
Methacholine—Vomiting—Metformin—polycystic ovary syndrome	0.00772	0.0138	CcSEcCtD
Methacholine—Headache—Metformin—polycystic ovary syndrome	0.00761	0.0136	CcSEcCtD
Methacholine—Nausea—Metformin—polycystic ovary syndrome	0.00722	0.0129	CcSEcCtD
Methacholine—CHRM3—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.00108	0.00246	CbGpPWpGaD
Methacholine—CHRM2—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.00107	0.00244	CbGpPWpGaD
Methacholine—CHRM3—Integration of energy metabolism—INS—polycystic ovary syndrome	0.00101	0.0023	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.001	0.00227	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.000991	0.00225	CbGpPWpGaD
Methacholine—CHRM3—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.00099	0.00225	CbGpPWpGaD
Methacholine—CHRM2—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.00098	0.00223	CbGpPWpGaD
Methacholine—CHRM2—SIDS Susceptibility Pathways—NR3C1—polycystic ovary syndrome	0.000955	0.00217	CbGpPWpGaD
Methacholine—CHRM3—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.000953	0.00217	CbGpPWpGaD
Methacholine—CHRM2—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.000944	0.00214	CbGpPWpGaD
Methacholine—CHRM3—GPCR ligand binding—LHB—polycystic ovary syndrome	0.000941	0.00214	CbGpPWpGaD
Methacholine—CHRM2—GPCR ligand binding—LHB—polycystic ovary syndrome	0.000932	0.00212	CbGpPWpGaD
Methacholine—CHRM3—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.00092	0.00209	CbGpPWpGaD
Methacholine—CHRM2—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.000911	0.00207	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—NPB—polycystic ovary syndrome	0.000909	0.00207	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.000905	0.00206	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—NPB—polycystic ovary syndrome	0.0009	0.00205	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.000897	0.00204	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.000886	0.00201	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.000886	0.00201	CbGpPWpGaD
Methacholine—CHRM3—GPCR ligand binding—SCT—polycystic ovary syndrome	0.000882	0.002	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.000878	0.00199	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.000878	0.00199	CbGpPWpGaD
Methacholine—CHRM2—GPCR ligand binding—SCT—polycystic ovary syndrome	0.000874	0.00199	CbGpPWpGaD
Methacholine—CHRM3—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.000842	0.00191	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.000836	0.0019	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.000836	0.0019	CbGpPWpGaD
Methacholine—CHRM2—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.000833	0.00189	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.000827	0.00188	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.000827	0.00188	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.000822	0.00187	CbGpPWpGaD
Methacholine—CHRM3—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.000816	0.00185	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.000814	0.00185	CbGpPWpGaD
Methacholine—CHRM2—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.000808	0.00184	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—NMNAT3—polycystic ovary syndrome	0.000803	0.00183	CbGpPWpGaD
Methacholine—CHRM3—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.000789	0.00179	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.000782	0.00178	CbGpPWpGaD
Methacholine—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.000781	0.00177	CbGpPWpGaD
Methacholine—CHRM2—G alpha (i) signalling events—GNAS—polycystic ovary syndrome	0.00078	0.00177	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.000774	0.00176	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.000759	0.00172	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.000759	0.00172	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.000759	0.00172	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.000751	0.00171	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.000751	0.00171	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.000751	0.00171	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.000738	0.00168	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—SUOX—polycystic ovary syndrome	0.000735	0.00167	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—LPCAT2—polycystic ovary syndrome	0.000735	0.00167	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.000731	0.00166	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.00071	0.00161	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.000703	0.0016	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.000689	0.00157	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—ISYNA1—polycystic ovary syndrome	0.000683	0.00155	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.000682	0.00155	CbGpPWpGaD
Methacholine—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.000676	0.00154	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.000672	0.00153	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.00067	0.00152	CbGpPWpGaD
Methacholine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.000669	0.00152	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.000665	0.00151	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.000664	0.00151	CbGpPWpGaD
Methacholine—CHRM3—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.000622	0.00141	CbGpPWpGaD
Methacholine—CHRM2—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.000616	0.0014	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000614	0.0014	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.000612	0.00139	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.00061	0.00139	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000608	0.00138	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.000606	0.00138	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.000604	0.00137	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—AKR1C2—polycystic ovary syndrome	0.000581	0.00132	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—TEAD2—polycystic ovary syndrome	0.000581	0.00132	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.000559	0.00127	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.000555	0.00126	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.000554	0.00126	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.00055	0.00125	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000538	0.00122	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—NPB—polycystic ovary syndrome	0.000537	0.00122	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000533	0.00121	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.000532	0.00121	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—NPB—polycystic ovary syndrome	0.000532	0.00121	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.000527	0.0012	CbGpPWpGaD
Methacholine—CHRM2—G alpha (i) signalling events—POMC—polycystic ovary syndrome	0.000525	0.00119	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.00052	0.00118	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000515	0.00117	CbGpPWpGaD
Methacholine—CHRM3—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.000515	0.00117	CbGpPWpGaD
Methacholine—CHRM2—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.00051	0.00116	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.000508	0.00115	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.000503	0.00114	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000499	0.00113	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000494	0.00112	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000489	0.00111	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PNPLA2—polycystic ovary syndrome	0.000487	0.00111	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000486	0.0011	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000484	0.0011	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000483	0.0011	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000481	0.00109	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000478	0.00109	CbGpPWpGaD
Methacholine—CHRM3—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000477	0.00108	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000476	0.00108	CbGpPWpGaD
Methacholine—CHRM2—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000472	0.00107	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000472	0.00107	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000471	0.00107	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000468	0.00106	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—SRD5A1—polycystic ovary syndrome	0.000461	0.00105	CbGpPWpGaD
Methacholine—CHRM2—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.000458	0.00104	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000453	0.00103	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000448	0.00102	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000448	0.00102	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000448	0.00102	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000444	0.00101	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000444	0.00101	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—STAR—polycystic ovary syndrome	0.00044	0.001	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000432	0.000981	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000428	0.000972	CbGpPWpGaD
Methacholine—CHRM3—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000422	0.000959	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000419	0.000953	CbGpPWpGaD
Methacholine—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000418	0.000949	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000415	0.000943	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000407	0.000925	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000403	0.000916	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000396	0.0009	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—HMMR—polycystic ovary syndrome	0.000392	0.000892	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000392	0.000891	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000386	0.000877	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000382	0.000868	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—HSD3B1—polycystic ovary syndrome	0.000374	0.000851	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.00036	0.000819	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000357	0.000811	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000351	0.000798	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000348	0.00079	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—LHB—polycystic ovary syndrome	0.000341	0.000776	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—HSD3B2—polycystic ovary syndrome	0.000334	0.000758	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000328	0.000746	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000325	0.000738	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—AKR1C1—polycystic ovary syndrome	0.000323	0.000734	CbGpPWpGaD
Methacholine—CHRM3—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000321	0.00073	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000319	0.000725	CbGpPWpGaD
Methacholine—CHRM2—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000318	0.000723	CbGpPWpGaD
Methacholine—CHRM2—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000317	0.00072	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000316	0.000718	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000308	0.000701	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000305	0.000694	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.0003	0.000682	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—SULT2A1—polycystic ovary syndrome	0.000297	0.000676	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000297	0.000675	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—FST—polycystic ovary syndrome	0.000292	0.000664	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000291	0.000661	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—FST—polycystic ovary syndrome	0.00029	0.000658	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000289	0.000656	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—RRM2—polycystic ovary syndrome	0.000288	0.000654	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000288	0.000654	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000286	0.00065	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—LHB—polycystic ovary syndrome	0.000285	0.000649	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—LHB—polycystic ovary syndrome	0.000283	0.000642	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000279	0.000634	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—YAP1—polycystic ovary syndrome	0.000278	0.000631	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000276	0.000628	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.00027	0.000614	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.00027	0.000613	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000268	0.000608	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—SCT—polycystic ovary syndrome	0.000267	0.000608	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000267	0.000607	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—NAMPT—polycystic ovary syndrome	0.000267	0.000606	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—SCT—polycystic ovary syndrome	0.000265	0.000602	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000264	0.0006	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—CYP11A1—polycystic ovary syndrome	0.000263	0.000599	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000261	0.000594	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000255	0.00058	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000253	0.000574	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000251	0.00057	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—AKR1C3—polycystic ovary syndrome	0.000249	0.000565	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000249	0.000565	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000248	0.000564	CbGpPWpGaD
Methacholine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000248	0.000562	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000246	0.00056	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—CYP17A1—polycystic ovary syndrome	0.000245	0.000556	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000245	0.000556	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000242	0.000551	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000232	0.000527	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—YAP1—polycystic ovary syndrome	0.00023	0.000522	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000229	0.00052	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000227	0.000515	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—INSR—polycystic ovary syndrome	0.000219	0.000497	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—INSR—polycystic ovary syndrome	0.000217	0.000493	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—TH—polycystic ovary syndrome	0.000212	0.000481	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000208	0.000473	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—SLC2A4—polycystic ovary syndrome	0.000206	0.000468	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000206	0.000468	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000205	0.000465	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000203	0.000461	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PGR—polycystic ovary syndrome	0.000203	0.000461	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PGR—polycystic ovary syndrome	0.000201	0.000456	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—CYP19A1—polycystic ovary syndrome	0.000194	0.00044	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000188	0.000428	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000188	0.000428	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000187	0.000424	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000187	0.000424	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000182	0.000412	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.00018	0.000408	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—ATF1—polycystic ovary syndrome	0.00018	0.000408	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000178	0.000405	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000175	0.000398	CbGpPWpGaD
Methacholine—CHRM3—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000174	0.000396	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000174	0.000394	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—GNAS—polycystic ovary syndrome	0.000173	0.000393	CbGpPWpGaD
Methacholine—CHRM2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000173	0.000393	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000166	0.000377	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000165	0.000375	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—NCOR1—polycystic ovary syndrome	0.000165	0.000374	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—PRL—polycystic ovary syndrome	0.000164	0.000374	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000164	0.000373	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000163	0.000371	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—PRL—polycystic ovary syndrome	0.000163	0.00037	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000158	0.00036	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000157	0.000357	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—CYP1A1—polycystic ovary syndrome	0.000156	0.000355	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000156	0.000354	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000154	0.000351	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—MTHFR—polycystic ovary syndrome	0.000146	0.000331	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000145	0.000329	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000143	0.000325	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000138	0.000313	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000136	0.00031	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000135	0.000307	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000134	0.000304	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—PPARG—polycystic ovary syndrome	0.000118	0.000268	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—POMC—polycystic ovary syndrome	0.000116	0.000265	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000116	0.000263	CbGpPWpGaD
Methacholine—CHRM3—Metabolism—INS—polycystic ovary syndrome	0.000116	0.000263	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000115	0.000261	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—LEP—polycystic ovary syndrome	0.000113	0.000258	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—LEP—polycystic ovary syndrome	0.000112	0.000255	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000101	0.00023	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—IRS1—polycystic ovary syndrome	0.0001	0.000228	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—POMC—polycystic ovary syndrome	9.74e-05	0.000221	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—INS—polycystic ovary syndrome	9.68e-05	0.00022	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—POMC—polycystic ovary syndrome	9.64e-05	0.000219	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—INS—polycystic ovary syndrome	9.59e-05	0.000218	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—IGF1—polycystic ovary syndrome	9.37e-05	0.000213	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—AKT2—polycystic ovary syndrome	9.36e-05	0.000213	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—IGF1—polycystic ovary syndrome	9.28e-05	0.000211	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—AKT2—polycystic ovary syndrome	9.27e-05	0.000211	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.9e-05	0.000202	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.81e-05	0.0002	CbGpPWpGaD
Methacholine—CHRM3—Signaling by GPCR—IL6—polycystic ovary syndrome	7.16e-05	0.000163	CbGpPWpGaD
Methacholine—CHRM2—Signaling by GPCR—IL6—polycystic ovary syndrome	7.09e-05	0.000161	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.12e-05	0.000139	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.06e-05	0.000138	CbGpPWpGaD
Methacholine—CHRM3—Signaling Pathways—IL6—polycystic ovary syndrome	4.23e-05	9.62e-05	CbGpPWpGaD
Methacholine—CHRM2—Signaling Pathways—IL6—polycystic ovary syndrome	4.19e-05	9.52e-05	CbGpPWpGaD
